466 related articles for article (PubMed ID: 16607286)
1. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
2. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
Fischer AN; Fuchs E; Mikula M; Huber H; Beug H; Mikulits W
Oncogene; 2007 May; 26(23):3395-405. PubMed ID: 17130832
[TBL] [Abstract][Full Text] [Related]
3. Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.
Fischer AN; Herrera B; Mikula M; Proell V; Fuchs E; Gotzmann J; Schulte-Hermann R; Beug H; Mikulits W
Carcinogenesis; 2005 May; 26(5):931-42. PubMed ID: 15705598
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
5. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
7. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
Mikula M; Gotzmann J; Fischer AN; Wolschek MF; Thallinger C; Schulte-Hermann R; Beug H; Mikulits W
Oncogene; 2003 Oct; 22(43):6725-38. PubMed ID: 14555986
[TBL] [Abstract][Full Text] [Related]
8. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I
Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
12. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
15. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.
Kojima T; Takano K; Yamamoto T; Murata M; Son S; Imamura M; Yamaguchi H; Osanai M; Chiba H; Himi T; Sawada N
Liver Int; 2008 Apr; 28(4):534-45. PubMed ID: 18031476
[TBL] [Abstract][Full Text] [Related]
17. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
18. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
20. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
Lahsnig C; Mikula M; Petz M; Zulehner G; Schneller D; van Zijl F; Huber H; Csiszar A; Beug H; Mikulits W
Oncogene; 2009 Feb; 28(5):638-50. PubMed ID: 19015638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]